These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12482781)

  • 1. Histopathology of coronary in-stent restenosis following gamma brachytherapy.
    Lowe HC; Mino M; Mark EJ; Mac Neill BD; Palacios IF; Houser SL
    Heart; 2003 Jan; 89(1):11-3. PubMed ID: 12482781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary in-stent restenosis following beta brachytherapy: a histopathological examination.
    Witzke CF; MacNeill BD; Lowe HC; Houser SL; Palacios IF
    Cardiovasc Pathol; 2004; 13(2):85-90. PubMed ID: 15033157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological features of in-stent restenosis after sirolimus-eluting stent versus bare metal stent placement.
    Abe S; Yoneda S; Kanaya T; Oda K; Nishino S; Kageyama M; Taguchi I; Masawa N; Inoue T
    Cardiovasc Pathol; 2012; 21(2):e19-22. PubMed ID: 21489821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of patients with in-stent restenosis.
    Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
    EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy.
    Ortolani P; Marzocchi A; Aquilina M; Gaiba W; Neri S; Bunkheila F; Lombardo E; Pini S; Marrozzini C; Palmerini T; Taglieri N; Sbarzaglia P; Reggiani ML; Barbieri E; Branzi A
    Catheter Cardiovasc Interv; 2004 Dec; 63(4):433-8. PubMed ID: 15558757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilic infiltration in restenotic tissue following coronary stent implantation.
    Rittersma SZ; Meuwissen M; van der Loos CM; Koch KT; de Winter RJ; Piek JJ; van der Wal AC
    Atherosclerosis; 2006 Jan; 184(1):157-62. PubMed ID: 15950231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of 32P beta brachytherapy failure in patients with high-risk in-stent restenosis.
    Ortolani P; Marzocchi A; Aquilina M; Gaiba W; Bunkheila F; Neri S; Lombardo E; Marrozzini C; Pini S; Taglieri N; Sbarzaglia P; Reggiani ML; Barbieri E; Branzi A
    Cardiovasc Radiat Med; 2004; 5(2):77-83. PubMed ID: 15464944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions.
    Costantini CO; Lansky AJ; Mintz GS; Shirai K; Dangas G; Mehran R; Fahy M; Slack S; Coral M; Teirstein PS; Waksman R; Stone G; Moses J; Leon MB
    J Am Coll Cardiol; 2003 May; 41(10):1725-31. PubMed ID: 12767655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human in-stent restenosis tissue obtained by means of coronary atherectomy consists of an abundant proteoglycan matrix with a paucity of cell proliferation.
    Glover C; Ma X; Chen YX; Miller H; Veinot J; Labinaz M; O'Brien E
    Am Heart J; 2002 Oct; 144(4):702-9. PubMed ID: 12360168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis.
    Schukro C; Syeda B; Kirisits C; Schmid R; Pichler P; Pokrajac B; Lang I; Pötter R; Glogar D
    Radiother Oncol; 2007 Jan; 82(1):18-23. PubMed ID: 16971011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 32P brachytherapy in the treatment of complex Cypher in-stent restenosis.
    Ortolani P; Marzocchi A; Aquilina M; Gaiba W; Neri S; Marrozzini C; Palmerini T; Taglieri N; Branzi A
    J Interv Cardiol; 2005 Jun; 18(3):205-11. PubMed ID: 15966927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of angiographic and clinical outcomes between rotational atherectomy versus balloon angioplasty followed by radiation therapy with a rhenium-188-mercaptoacetyltriglycine-filled balloon in the treatment of diffuse in-stent restenosis.
    Lee SW; Park SW; Hong MK; Lee JH; Kim YH; Moon DH; Oh SJ; Lee CW; Kim JJ; Park SJ
    Int J Cardiol; 2005 Jul; 102(2):179-85. PubMed ID: 15982482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ultrasound analysis from the TAXUS-V ISR trial.
    Koizumi T; Fitzgerald PJ; Honda Y; Ellis SG; Kent K; Martin SL; Brown CL; Masud AR; Patterson JB; Greenberg J; Friedman M; Uchida T; Stone GW
    Cardiovasc Revasc Med; 2010; 11(3):140-8. PubMed ID: 20599163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary in-stent restenosis: current status and future strategies.
    Lowe HC; Oesterle SN; Khachigian LM
    J Am Coll Cardiol; 2002 Jan; 39(2):183-93. PubMed ID: 11788206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late restenosis following placement of a sirolimus eluting stent for in-stent restenosis.
    Ali OA; Lowe H; Kritharides L; Brieger D
    Heart Lung Circ; 2007 Feb; 16(1):50-1. PubMed ID: 17196881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-Stent Restenosis with "Inflammatory" Neointima Following Everolimus-Eluting Stent Implantation.
    Tsuji Y; Koide M; Katsura K; Fujita H; Ishibashi-Ueda H; Otsuka F
    Int Heart J; 2018 Sep; 59(5):1142-1145. PubMed ID: 30012926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravascular optical coherence tomographic (OCT) findings late after intracoronary beta brachytherapy.
    Doustaly R; Siegwald J; Naoum C; Yong AS; Savvides M; Lowe HC
    Int J Cardiol; 2013 Oct; 168(3):e87-8. PubMed ID: 23928343
    [No Abstract]   [Full Text] [Related]  

  • 18. Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis.
    Werner GS; Emig U; Krack A; Schwarz G; Figulla HR
    Catheter Cardiovasc Interv; 2004 Nov; 63(3):259-64. PubMed ID: 15505841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation.
    Chu WW; Torguson R; Pichard AD; Satler LF; Chan R; Porrazzo M; Kent KM; Suddath WO; Waksman R
    J Invasive Cardiol; 2005 Dec; 17(12):659-62. PubMed ID: 16327049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of Intracoronary Brachytherapy for Patients With Resistant Drug-Eluting Stent Restenosis.
    Mangione FM; Jatene T; Badr Eslam R; Bergmark BA; Gallagher JR; Shah PB; Mauri L; Leopold JA; Sobieszczyk PS; Faxon DP; Croce KJ; Bhatt DL; Devlin PM
    Am J Cardiol; 2017 Aug; 120(3):369-373. PubMed ID: 28583681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.